Loading…
EE668 Empagliflozin for the Treatment of Adult Patients With Symptomatic Chronic Heart Failure With Reduced Ejection Fraction (HFREF): A Cost-Effectiveness Analysis From the Italian NHS Perspective
Saved in:
Published in: | Value in health 2022-12, Vol.25 (12), p.S188-S188 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 1098-3015 1524-4733 |
DOI: | 10.1016/j.jval.2022.09.907 |